DrugsControl Media Services

News Detail

Biotech industry seeks removal of regulatory hurdles to accelerate growth of biologics (12-10-2021)

Mumbai, 12 Oct 2021: In a bid to accelerate biologics and biosimilar development in India, biotech industry is looking for a slew of regulatory reforms including doing away with requirement of no objection certificate (NOC) for issuance of Form 29, scrapping provision requiring a......
View Details

Source : Pharmabiz

Related News